Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-01-11 Sale |
2024-01-12 5:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer |
9,229 | $0.84654 | $7,813 | 7,874 (Direct) |
View |
| 2024-01-11 Sale |
2024-01-12 5:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer |
29,202 | $0.84698 | $24,734 | 26,388 (Direct) |
View |
| 2024-01-11 Sale |
2024-01-12 5:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
9,229 | $0.84654 | $7,813 | 7,874 (Direct) |
View |
| 2023-09-01 Sale |
2023-09-01 7:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer |
2,403 | $0.78 | $1,874 | 3,449 (Direct) |
View |
| 2023-08-01 Sale |
2023-08-01 5:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
3,096 | $0.9056 | $2,804 | 4,718 (Direct) |
View |
| 2023-07-10 Sale |
2023-07-10 5:01 pm |
Adaptimmune Therapeutics PLC | ADAP | Menzel Garry E Director |
47,702 | $0.9108 | $43,447 | 75,056 (Direct) |
View |
| 2023-06-27 Sale |
2023-06-27 9:15 pm |
Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer |
2,333 | $0.92 | $2,146 | 3,519 (Direct) |
View |
| 2023-01-31 Sale |
2023-01-31 9:02 pm |
Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer |
11,890 | $1.8696 | $22,230 | 19,535 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-17 9:17 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
4,440 | $1.858 | $8,250 | 7,264 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-17 9:17 pm |
Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer |
4,440 | $1.858 | $8,250 | 7,264 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-17 9:16 pm |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
2,159 | $1.858 | $4,011 | 3,491 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-17 9:15 pm |
Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer |
10,057 | $1.858 | $18,686 | 13,351 (Direct) |
View |
| 2023-01-11 Sale |
2023-01-12 9:03 pm |
Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer |
8,816 | $1.7238 | $15,197 | 8,121 (Direct) |
View |
| 2023-01-11 Sale |
2023-01-12 9:02 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
8,816 | $1.7238 | $15,197 | 8,121 (Direct) |
View |
| 2023-01-11 Sale |
2023-01-12 9:01 pm |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
11,292 | $1.7199 | $19,421 | 12,191 (Direct) |
View |
| 2023-01-11 Sale |
2023-01-12 9:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer |
31,805 | $1.7227 | $54,791 | 24,882 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2023-11-01 5:00 pm |
N/A 2033-11-01 |
Adaptimmune Therapeutics PLC | ADAP | Hege Kristen Director |
0 | $0 | 1,000,000 (Direct) |
View |
| 2023-07-05 Option Award |
2023-07-05 5:05 pm |
N/A 2031-08-24 |
Adaptimmune Therapeutics PLC | ADAP | Hegde Priti Director |
488,586 | $0 | 488,586 (Direct) |
View |
| 2023-07-05 Option Award |
2023-07-05 5:03 pm |
N/A 2028-12-12 |
Adaptimmune Therapeutics PLC | ADAP | Allen Andrew R Director |
547,296 | $0 | 547,296 (Direct) |
View |
| 2023-07-05 Option Award |
2023-07-05 5:00 pm |
N/A 2024-03-15 |
Adaptimmune Therapeutics PLC | ADAP | Menzel Garry E Director |
10,848,678 | $0 | 10,848,678 (Direct) |
View |
| 2023-07-03 Option Award |
2023-07-03 5:16 pm |
2024-07-03 2033-07-03 |
Adaptimmune Therapeutics PLC | ADAP | Behbahani Ali Director |
933,317 | $0 | 933,317 (Direct) |
View |
| 2023-07-03 Option Award |
2023-07-03 5:04 pm |
2024-07-03 2033-07-03 |
Adaptimmune Therapeutics PLC | ADAP | Hegde Priti Director |
500,000 | $0 | 500,000 (Direct) |
View |
| 2023-07-03 Option Award |
2023-07-03 5:04 pm |
2024-07-03 2033-07-03 |
Adaptimmune Therapeutics PLC | ADAP | Furey John Director |
500,000 | $0 | 500,000 (Direct) |
View |
| 2023-07-03 Option Award |
2023-07-03 5:03 pm |
2024-07-03 2033-07-03 |
Adaptimmune Therapeutics PLC | ADAP | Menzel Garry E Director |
981,463 | $0 | 981,463 (Direct) |
View |
| 2023-07-03 Option Award |
2023-07-03 5:02 pm |
2024-07-03 2033-07-03 |
Adaptimmune Therapeutics PLC | ADAP | Sigal Charles Elliott Director |
933,317 | $0 | 933,317 (Direct) |
View |
| 2023-07-03 Option Award |
2023-07-03 5:02 pm |
2024-07-03 2033-07-03 |
Adaptimmune Therapeutics PLC | ADAP | Alleva Lawrence M Director |
1,077,756 | $0 | 1,077,756 (Direct) |
View |
| 2023-07-03 Option Award |
2023-07-03 5:01 pm |
2024-07-03 2033-07-03 |
Adaptimmune Therapeutics PLC | ADAP | MOTT DAVID M Director |
1,462,927 | $0 | 1,462,927 (Direct) |
View |
| 2023-07-03 Option Award |
2023-07-03 5:00 pm |
2024-07-03 2033-07-03 |
Adaptimmune Therapeutics PLC | ADAP | Allen Andrew R Director |
500,000 | $0 | 500,000 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-01 4:59 pm |
N/A N/A |
Adaptimmune Therapeutics PLC | ADAP | Menzel Garry E Director |
611,224 | $0 | 410,578 (Indirect) |
View |
| 2023-01-17 Option Award |
2023-01-17 9:07 pm |
N/A 2033-01-17 |
Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer |
1,924,128 | $0 | 1,924,128 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-17 9:06 pm |
N/A 2033-01-17 |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
1,912,248 | $0 | 1,912,248 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-17 9:05 pm |
N/A 2033-01-17 |
Adaptimmune Therapeutics PLC | ADAP | Brewer Joanna Elizabeth Chief Scientific Officer |
1,856,808 | $0 | 1,856,808 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-17 9:04 pm |
N/A 2033-01-17 |
Adaptimmune Therapeutics PLC | ADAP | TAYTON-MARTIN HELEN KATRINA Chief Business & Strgy Officer |
1,918,392 | $0 | 1,918,392 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-17 9:04 pm |
N/A 2033-01-17 |
Adaptimmune Therapeutics PLC | ADAP | Wood Gavin Chief Financial Officer |
1,915,056 | $0 | 1,915,056 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-17 9:03 pm |
N/A 2033-01-17 |
Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer |
1,914,672 | $0 | 1,914,672 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-17 9:02 pm |
N/A 2033-01-17 |
Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer |
1,902,888 | $0 | 1,902,888 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-17 9:01 pm |
N/A 2033-01-17 |
Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer |
6,488,496 | $0 | 6,488,496 (Direct) |
View |